Member Info for Fruitsnveg

No question about it; this will be a very important drug for critical care use in MVP, if it is proven to work in the identified group.

Weird. The final window of my calendar says "Tattyhead is the Christmas Clown of Tinseltown"

I notice neither Mr Hennings nor Mr Francis have updated their Linkedin profiles either, to state their roles at Synairgen are 'past', as opposed to still 'current'. It seems a common oversight at SNG HQ, forgetting to update one's public-facing profile....

Bob,

Well observed. If it waddles like a duck, and it quacks like a duck, its a duck.

"It grieves me that whatever deal is struck now could have happened at any time in the last three years and saved an awful lot of people losing an awful lot of money."

We know there's been plenty of work going on behind the scenes to get the company to the point of being able to identify clearly those patients whose fires need to be put out. I'm sure all the hard work that has gone on in the background, on which we must surely be dependent, will undoubtedly be revealed soon.

Just because you won't admit it, doesn't mean it isn't so....

Why the constant jab Aether, forever trying to make it out that fellow posters Tommy, Gunto and are in cahoots just because we have views independent of yours and you coveted circle? Are you suggesting that we the same poster, or related?

"Anyone looking to take part in the upcoming raise should absolutely look at this as if it is a brand new investment, because we are starting new trials, mostly new BOD etc."

It's not mostly new BOD though is it, and it's not a new company either, it's 25+ yrs old. It has to be viewed warts and all. You've been keen to point out it's flaws and complain about strategy a lot, then you can't suddenly proclaim it a new company with no history! So, if investors don't like the current management, then I would suggest that hey don't get involved in any raise.

"If this gets over the line, it won't be thanks to RM"

I have to disagree. Like him or not, it's the CEO who is ultimately in charge of the company, top of the decision tree. If you applaud a future deal, trial result or strategy move, know that the CEO will have had substantive input.

I understand the holding to account and judgement on whether exec. salaries feel sufficiently earned, or not, but I do think we have reached a point of exhaustion on that point. The AGM was preceded by almost a year of such complaints, and when put to the vote the Directors remuneration as overwhelmingly supported by shareholder votes. So, although I acknowledge a very small minority (not my estimation but per the actual voting results) agitated against this, as is their right, support for the Management team remuneration remuneration actually robust. With all of that in mind, discussing it ad nauseum serves little. The people (shareholders) have spoken and supported those salaries by voting each year n the AGM. They haven't "all somehow hung onto them in the years since." Those salaries have been sanctioned by the shareholder collective. If you still feel strongly about it vote differently at the next AGM.

The median salary for CEOs in 2023 was £363,100 and would typically have increased by aprox. 5% since then, some 30+k more than the late-season lavender-scenting Sailor Marsden character described below.

I'm wondering what working title you employ for this exciting Mills & Boon type novella.........Scent of a CEO? Over Board? or maybe Sailors & Synners?

Small detail..... but the lavender season ended in August. Otherwise a lovely imaginative piece of creative writing.

....Exits room. Immediately calls British Airways to book a one way ticket to the Bahamas, in the next 4-6 weeks.

"Can't be anyone but TFG can it."

In reality, it can.

Imminent

"shareholder participation" - much like oft employed "immenent" , it may be open somewhat to interpretation, or do we think they mean it literally?

"It will be interesting to see how they mobilise the PI vote for the EGM"

What scenarios do you expect could play out?

Riveting stuff Axe.

I'm quietly confident. Years of experience on AIM has taught me well.

Honestly Spacman, I think you should let go of your grievances (as they vote has been cast there's not much to argue about), focus on the future, and decide if you want to be part of what will be presented soon by the BOD.

Your fellow shareholders would disagree, en masse it seems, with a whopping +90% voting on favour of re-appointment of Directors, including the CEO. I don't think there remains any doubt - support for Marsden has been strong, like it or not.

And? I'm not here for the bus stops. I'm here for the destination :-)